HIV Medicine

Contents
pp. 1-5(5)

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)
pp. 487-503(17)
Author: Gazzard, B

CD4 count and viral load time-courses in patients treated with highly active antiretroviral therapy and association with the CDC staging system
pp. 504-513(10)
Authors: Collazos, J; Knobel, H; Casado, JL

Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection
pp. 514-519(6)
Authors: Adalid-Peralta, L; Grangeot-Keros, L; Rudent, A; Ngo-Giang-Huong, N; Krzysiek, R; Goujard, C; Deveau, C; Le Gall, M; Meyer, L; Emilie, D; Rouzioux, C

Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response
pp. 520-529(10)
Authors: Fardet, L; Mary-Krause, M; Heard, I; Partisani, M; Costagliola, D

Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
pp. 530-536(7)
Authors: Bedimo, R; Ghurani, R; Nsuami, M; Turner, D; Kvanli, M-B; Brown, G; Margolis, D

Evaluation of nevirapine-switch strategies for HIV treatment
pp. 537-543(7)
Author: Cooper, CL

Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study
pp. 544-548(5)
Authors: Rihs, TA; Begley, K; Smith, DE; Sarangapany, J; Callaghan, A; Kelly, M; Post, JJ; Gold, J

Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients
pp. 549-557(9)
Authors: Orlando, G; Meraviglia, P; Cordier, L; Meroni, L; Landonio, S; Giorgi, R; Fasolo, M; Faggion, I; Riva, A; Zambelli, A; Beretta, R; Gubertini, G; Dedivitiis, G; Jacchetti, G; Cargnel, A

A note of thanks to referees Volume 7, 2006
pp. 558-559(2)